Single Arm Phase II Trial Using Canakinumab for the Prevention of Lung Cancer (Can-Prevent-Lung)

Condition:   Lung Cancer Interventions:   Drug: Atezolizumab;   Drug: Bevacizumab;   Drug: ADI-PEG 20 Sponsor:   M.D. Anderson Cancer Center Not yet recruiting

Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials